Woodline Partners’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
EAM
Woodline Partners's GH Position: Q2 2023 in Review
Woodline Partners sold out of Guardant Health (GH) in Q2 2023, closing a stake of 45,370 shares — an estimated $1.06M sold.
Woodline Partners first reported a position in GH in Q4 2020 and held it in 4 quarters. The position peaked at $4.5M in Q2 2021. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.
- Woodline Partners reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
- Woodline Partners sold 45,370 Guardant Health shares in Q2 2023, an estimated $1.06M.
- Woodline Partners first reported a position in Guardant Health in Q4 2020 and held it in 4 quarters.
- Woodline Partners's Guardant Health position peaked at $4.5M in Q2 2021.
- 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.